Oral contraceptive use, coffee consumption, and other risk factors of type 2 diabetes in women: a case–control study

JM Maksimovic, HD Vlajinac… - Journal of Substance …, 2024 - Taylor & Francis
Objectives The aim of the present study was to estimate risk factors for type 2 diabetes in
women. Methods A case–control study included 99 newly diagnosed cases of type 2 …

Systemic effects of clinical follicular fluid from polycystic ovary syndrome and non-polycystic ovary syndrome in female mice: Systemic effects of clinical follicular fluid …

N Gairola, H Chitme, R Sircar - Indian Journal of Experimental …, 2024 - or.niscpr.res.in
The follicular fluid's composition changes physiologically to meet the demands of specific
local phenomena during oogenesis and folliculogenesis. Here, we investigated whether …

FROM PATHOPHYSIOLOGY TO POTENTIAL INTERVENTIONS: INVESTIGATING THE INTRICATE DYNAMICS OF POLYCYSTIC OVARY SYNDROME, AGING, AND …

P Kabakchieva - Anti-Aging Eastern Europe, 2023 - antiagingeeu.com
Polycystic ovary syndrome (PCOS) and age-related decline in fertility are complex issues
affecting women's reproductive health. This review aims to explore the intricate dynamics …

Polycystic ovary syndrome–burden and adverse outcomes

A Subramanian - 2023 - etheses.bham.ac.uk
Background Polycystic ovary syndrome (PCOS) is the most common, yet underdiagnosed,
endocrine disorder in women of reproductive age, posing lifelong threats to their health with …

[PDF][PDF] The Im-plication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review. Metabolites 2023, 13, 129

AG Mukherjee, UR Wanjari, S Kannampuzha, R Murali… - 2023 - researchgate.net
As a complex endocrine and metabolic condition, polycystic ovarian syndrome (PCOS)
affects women's reproductive health. These common symptoms include hirsutism …

[HTML][HTML] Novel corticotropin-releasing hormone receptor genes (CRHR1 and CRHR2) linkage to and association with polycystic ovary syndrome

M Amin, N Horst, R Wu, C Gragnoli - Journal of Ovarian Research, 2023 - Springer
Background Women with polycystic ovarian syndrome (PCOS) have increased
hypothalamic–pituitary–adrenal (HPA) axis activation, pro-inflammatory mediators, and …

Metformin enhances the survival ability of ovarian granulosa cells in polycystic ovary syndrome by promoting LINC00548 to suppress androgen receptor/klotho …

G Pan, S Li, G Xiong, P Zhang, L Zhang… - Journal of Obstetrics … - Wiley Online Library
Abstract Background Metformin (Met) has been reported to play the key role in the
pathogenesis of polycystic ovary syndrome (PCOS). However, the precise mechanisms …

[PDF][PDF] O papel dos agentes insulino sensibilizantes na Síndrome do Ovário Poliquístico

ANARM DE SOUSA - 2024 - estudogeral.uc.pt
A Síndrome do Ovário Poliquístico (SOP) é uma condição comum em mulheres em idade
fértil, cuja fisiopatologia ainda não é totalmente compreendida, com múltiplos fatores …

[HTML][HTML] Commercially Available Injectables in Diabetes–Insulin, Incretins, and More

J Kesavadev, S Kalra, M John… - … Journal of Diabetes …, 2023 - journals.lww.com
The management of type 2 diabetes (T2D) has evolved significantly with the emergence of
diverse medication classes, including metformin, sulfonylureas, dipeptidyl peptidase-4 …

Síndrome dos ovários policísticos: análise de uma década de avanços e perspectivas-uma revisão abrangente da síndrome dos ovários policísticos

C Santiago - 2023 - repositorio.ufrn.br
RESUMO A SOP é uma prevalente condição endócrina que afeta mulheres, impactando a
homeostase metabólica e o sistema cardiovascular. Este estudo revisa os múltiplos critérios …